Article Details
Retrieved on: 2021-02-11 01:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Lytix Biopharma is investigating the safety and efficacy of LTX-315 and adoptive T cell therapy in an open-label Phase II single-center study in patients ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here